PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1182900
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1182900
Computer Aided Drug Discovery Market size was valued at USD 3,056.6 Million in 2021, expanding at a CAGR of 12.8% from 2022 to 2028.
Computer-aided drug discovery (CADD) is an effective computational tool used in drug development for the optimization of potential therapeutic compounds. Additionally, it also includes molecular design, molecular modeling, rational drug design, and computational chemistry. CADD has been used to improve the quality to accelerate the process of identified leads. Moreover, CADD techniques are well-linked and become an integral part of the academic sector and pharmaceutical sectors. Furthermore, it is time-saving, quick, and affordable. Due to such benefits, demand for computer-aided drug discovery is expected to increase during the forecast period.
The increasing usage of machine learning and artificial intelligence for drug development in healthcare sectors major factors are projected to increase the computer-aided drug discovery market demand. Additionally, the rising development of precious pharmaceutical research and increased chronic and undiagnosed disease is helping to increase the demand for drug development which is further expected to stimulate the CADD market growth. However, a shortage of skilled technicians to operate computer-aided drug discovery may hamper the market growth during the forecast period.
Moreover, CADD is the latest technique in which analysts and researcher monitor, develop, analyze, design, and study the 3D structure of target disease molecules and a combination of software using a complement biomolecule ligand. In addition, this method is popular among researchers due to its speed up drug discovery and research. The major factors to foster the market demand of the computer-aided drug discovery market. The COVID-19 pandemic had a devastating impact on several industries as the CADD market experienced momentous growth. To restrict the coronavirus disease spread CADD market has seen a high rate of growth due to increasing R&D activities among researchers, biotechnological, scientists, and biopharmaceutical companies. Across the world, the increasing spread of coronavirus has motivated scientists to discover an effective treatment or a drug against this deadly virus.
The Computer-Aided Drug Discovery Market is segmented on the basis of process, type, drug type, end-user, and by region.
The market is divided into five categories based on the process: target selection, target validation, candidate validation, hit-to-lead identification, and lead optimization. The hit-to-led identification segment is expected to possess the largest market share. Hit-to-led identification helps to contribute to CADD to identify hit compounds.
The market is divided into two categories based on type: chemistry service, and biology service. The chemistry service segment is expected to hold the largest market share during the forecast period. In various early drug development phases, the worldwide applications of chemistry deliver robust candidates.
The market is divided into eight categories based on drug type: small molecule drugs, biological drugs, drug discovery services market by therapeutic area, oncology, infectious and immune system disease, neurology, digestive system disease, cardiovascular disease, and others. The oncology segment is expected to dominate the market. It is a medicinal branch that deals with the prevention, treatment, and diagnosis of cancer. Cancer treatment is one of the major concerns globally due to resistance to medication. Based on this cancer drug demand is increasing that further helping the oncology segment grow.
The market is divided into two categories based on end-user: pharmaceuticals and biotechnology companies, academic institutes, and others. For identifying chemical compounds different types of approaches have been applied that need to be marked and developed. In addition, in pharmaceutical companies, the adoption of computer-aided drug discovery is estimated to grow the pharmaceutical segment.
The CADD market is growing rapidly due to the increasing combination of different technologies that increase research activities and provide results accurately in a lesser time. The latest technologies like machine learning and artificial intelligence increase the research programs in the pharmaceutical and biotechnological industries increasing the CADD market growth. Additionally, to discover new drugs for various chronic diseases many manufacturing companies have started investing a huge amount that will further help in CADD market growth.
For instance, in December 2021, Curia launched a Comprehensive messenger RNA (mRNA) drug substance. This includes process development, discovery, and mRNA drug substance production through lipid nanoparticle (LNP) formulation and development for full-scale sterile fill-finish services and large-scale lipid manufacturing.
The scope of this report covers the market by its major segments, which include as follows: